<code id='742489F4C4'></code><style id='742489F4C4'></style>
    • <acronym id='742489F4C4'></acronym>
      <center id='742489F4C4'><center id='742489F4C4'><tfoot id='742489F4C4'></tfoot></center><abbr id='742489F4C4'><dir id='742489F4C4'><tfoot id='742489F4C4'></tfoot><noframes id='742489F4C4'>

    • <optgroup id='742489F4C4'><strike id='742489F4C4'><sup id='742489F4C4'></sup></strike><code id='742489F4C4'></code></optgroup>
        1. <b id='742489F4C4'><label id='742489F4C4'><select id='742489F4C4'><dt id='742489F4C4'><span id='742489F4C4'></span></dt></select></label></b><u id='742489F4C4'></u>
          <i id='742489F4C4'><strike id='742489F4C4'><tt id='742489F4C4'><pre id='742489F4C4'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:3683
          glum Benjamin — health insurance coverage from STAT
          Adobe

          Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public within the past two years. All three used their stage time at the J.P. Morgan Healthcare Conference to make the case that their drastic decisions — like fully exiting some insurance markets — will deliver the profitability investors are demanding.

          “Insurance company profitability is the number one goal,” Oscar CEO Mario Schlosser said in an interview with STAT in San Francisco.

          advertisement

          “We are actually absolutely focused on profitability right now,” Clover CEO Andrew Toy said during his presentation on Wednesday.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
          JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

          FogPharmaCEOMathaiMammenVenrockSANFRANCISCO—SixmonthsintohistenureasCEOofcancerstartupFogPharma,Math

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

          2:18CarlosDeOliveira(L),propertymanagerofformerUSPresidentDonaldTrump'sMar-a-LagoestateinPalmBeach,a